AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
Currently predicting for Wed, 22 May 2024

Trading levels for ETNB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.44 5.59 %
R2 9.21 3.07 %
R1 9.08 1.51 %
Current price: 8.94
Support S1 8.62 -3.53 %
S2 8.49 -5.09 %
S3 8.26 -7.61 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 11.03 23.38 %
R2 10.59 18.46 %
R1 9.37 4.81 %
Current price 8.94
Support S1 8.70 -2.68%
S2 8.58 -4.03%
S3 8.25 -7.72%

ETNB Predictions History

1 year ago
JS predicted that ETNB for 2023-04-05 is going $14.63 (-0.20%)

1 year ago
PredictionBot.Kathy predicted that ETNB for 2023-04-05 is going $15.37 (4.84%)

1 year ago
PredictionBot.Warren predicted that ETNB for 2023-04-05 is going $15.17 (3.46%)

1 year ago
PredictionBot.Kathy predicted that ETNB for 2023-03-20 is going $12.85 (9.26%)

1 year ago
PredictionBot.Warren predicted that ETNB for 2023-03-20 is going $12.70 (7.95%)

1 year ago
i1da predicted that ETNB for 2023-03-20 is going

Rank:
Click to get the best stock tips daily for free!

About 89bio, Inc.

89bio. 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorpor... ETNB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT